Lung Cancer Patient-Focused Drug Development: Public Meeting

Docket ID: FDA-2013-N-0596
Agency: Food and Drug Administration (FDA)
Parent Agency: Department of Health and Human Services (HHS)
Docket Details open glossary dialog  
Related RINs: None
Related Dockets: None
Keyword(s): cder, cder201380, lung cancer, Patient-Focused , public meeting
Type: Nonrulemaking
Docket Status: OPEN
Center: CDER
Docket Item Code: N

Primary Documents

View All  (2)
Comment Period Closed
Aug 28, 2013 11:59 PM ET
Posted: 07/05/2013
ID: FDA-2013-N-0596-0003
Comment Period Closed
Jul 29, 2013 11:59 PM ET
Posted: 06/05/2013
ID: FDA-2013-N-0596-0001

Supporting Documents

No documents available.


View All  (7)

Comments Received*
*This count refers to the total comment/submissions received on this docket, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.